Stocks
ALPS Medical Breakthroughs ETFSBIO
AMEXHealthcareBiotechnology$49.81-0.74%
Price as of · delayed, not real-time
This ETF focuses on small- and mid-cap biotechnology and pharmaceutical companies that are developing innovative medical treatments. It is particularly relevant for investors seeking exposure to high-growth potential in the healthcare sector, especially in companies with breakthrough therapies or technologies.
Market Cap: $133.3M52W Range: $22.33 – $54.79
Congressional Interest in ALPS Medical Breakthroughs ETF (SBIO)
1 member of Congress has disclosed 9 trades in ALPS Medical Breakthroughs ETF (SBIO), a Healthcare company. The buy/sell breakdown shows 3 purchases versus 6 sales, indicating net selling pressure from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
9
Unique Politicians
1
Buys
3
Sells
6
Who in Congress Is Trading SBIO?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2023-04-17 | Thomas R Carper | sell | $1K – $15K |
| 2023-02-15 | Thomas R Carper | sell | $1K – $15K |
| 2022-10-04 | Thomas R Carper | sell | $1K – $15K |
| 2022-03-07 | Thomas R Carper | sell | $1K – $15K |
| 2021-12-31 | Thomas R Carper | sell | $1K – $15K |
| 2021-11-29 | Thomas R Carper | buy | $1K – $15K |
| 2020-12-30 | Thomas R Carper | buy | $1K – $15K |
| 2020-11-20 | Thomas R Carper | buy | $1K – $15K |
| 2020-04-02 | Thomas R Carper | sell | $1K – $15K |